Abstract
B-Myb is a highly conserved member of the Myb family of transcription factors whose activity is regulated during the cell cycle. Previous work has shown that the activity of B-Myb is stimulated by cyclin A/Cdk2-dependent phosphorylation whereas interaction of B-Myb with cyclin D1 inhibits its activity. Here, we have investigated the role of p300 as a coactivator for B-Myb. We show that B-Myb-dependent transactivation is stimulated by p300 as a result of interaction between B-Myb and p300. We have mapped the sequences responsible for the interaction of B-Myb and p300 to the E1A-binding region of p300 and the transactivation domain of B-Myb, respectively. Furthermore, our data suggest that phosphorylation of B-Myb stimulates its acetylation by p300 and that the acetylation of B-Myb is necessary for the full stimulation of its transactivation potential by p300. We have also studied the effect of cyclin D1 on the cooperation of B-Myb and p300. Based on our results we propose that cyclin D1 inhibits the activity of B-Myb by interfering with the interaction of B-Myb and p300. The data reported here provide novel insight into the mechanisms by which the activity of B-Myb is regulated during the cell cycle. Taken together they suggest that the coactivator p300 plays an important role in this regulation and that the cooperation of B-Myb and p300 is orchestrated by cyclins A and D1.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ait-Si-Ali S, Polesskaya A, Filleur S, Ferreira R, Duquet A, Robin P, Vervish A, Trouche D, Cabon F and Harel-Bellan A . (2000). Oncogene, 19, 2430–2437.
Ait-Si-Ali S, Ramirez S, Barre FX, Dkhissi F, Magnaghi-Jaulin L, Girault JA, Robin P, Knibiehler M, Pritchard LL, Ducommun B, Trouche D and Harel-Bellan A . (1998). Nature, 396, 184–186.
Arany Z, Newsome D, Oldread E, Livingston DM and Eckner R . (1995). Nature, 374, 81–84.
Arias J, Alberts AS, Brindle P, Claret FX, Smeal T, Karin M, Feramisco J and Montminy M . (1994). Nature, 370, 226–229.
Arsura M, Introna M, Passerini F, Mantovani A and Golay J . (1992). Blood, 79, 2708–2716.
Avantaggiati ML, Ogryzko V, Gardner K, Giordano A, Levine AS and Kelly K . (1997). Cell, 89, 1175–1184.
Bannister AJ and Kouzarides T . (1995). EMBO J., 14, 4758–4762.
Bannister AJ and Kouzarides T . (1996). Nature, 384, 641–643.
Bannister AJ, Oehler T, Wilhelm D, Angel P and Kouzarides T . (1995). Oncogene, 11, 2509–2514.
Bartsch O, Horstmann S, Toprak K, Klempnauer K-H and Ferrari S . (1999). Eur. J. Biochem., 260, 384–391.
Bernards R . (1999). Biochim. Biophys. Acta, 1424, M17–M22.
Bessa M, Saville MK and Watson RJ . (2001). Oncogene, 20, 3376–3386.
Bienvenu F, Gaseun H and Coqueret O . (2001). J. Biol. Chem., 276, 16840–16847.
Bouwmeester T, Guehmann S, el-Baradi T, Kalkbrenner F, van Wijk I, Moelling K and Pieler T . (1992). Mech. Dev., 37, 57–68.
Chakravarti D, LaMorte VJ, Nelson MC, Nakajima T, Schulman IG, Juguilon H, Montminy M and Evans RM . (1996). Nature, 383, 99–103.
Charrasse S, Carena I, Brondani V, Klempnauer K-H and Ferrari S . (2000). Oncogene, 19, 2986–2995.
Chrivia JC, Kwok RP, Lamb N, Hagiwara M, Montminy MR and Goodman RH . (1993). Nature, 365, 855–859.
Dai P, Akimaru H, Tanaka Y, Hou DX, Yasukawa T, Kanei-Ishii C, Takahashi T and Ishii S . (1996). Genes Dev., 10, 528–540.
Diehl JA, Cheng M, Roussel MF and Sherr CJ . (1998). Genes Dev., 12, 3499–3511.
Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A and Weinberg RA . (1993). Cell, 73, 499–511.
Draetta GF . (1994). Curr. Opin. Cell. Biol., 6, 842–846.
Eckner R, Ewen ME, Newsome D, Gerdes M, DeCaprio JA, Lawrence JB and Livingston DM . (1994). Genes Dev., 8, 869–884.
Facchinetti V, Loffarelli L, Schreek S, Oelgeschlager M, Luscher B, Introna M and Golay J . (1997). Biochem. J., 324, 729–736.
Foos G, Grimm S and Klempnauer K-H . (1992). EMBO J., 11, 4619–4629.
Ganter B, Fu S and Lipsick JS . (1998). EMBO J., 17, 255–268.
Giordano A and Avantaggiati ML . (1999). J. Cell. Physiol., 181, 218–230.
Goodman RH and Smolik S . (2000). Genes Dev., 14, 1553–1577.
Gu W, Shi XL and Roeder RG . (1997). Nature, 387, 819–823.
Hasan S, Hassa PO, Imhof R and Hottiger MO . (2001). Nature, 410, 387–391.
Hecht A, Vleminckx K, Stemmler MP, van Roy F and Kemler R . (2000). EMBO J., 19, 1839–1850.
Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI and Weinberg RA . (1992). Cell, 70, 993–1006.
Hirai H and Sherr CJ . (1996). Mol. Cell. Biol., 16, 6457–6467.
Horstmann S, Ferrari S and Klempnauer K-H . (2000a). Oncogene, 19, 5428–5434.
Horstmann S, Ferrari S and Klempnauer K-H . (2000b). Oncogene, 19, 298–306.
Imhof A, Yang XJ, Ogryzko VV, Nakatani Y, Wolffe AP and Ge H . (1997). Curr. Biol., 7, 689–692.
Inoue K and Sherr CJ . (1998). Mol. Cell. Biol., 18, 1590–1600.
Janknecht R and Hunter T . (1996). Curr. Biol., 6, 951–954.
Janknecht R and Nordheim A . (1996). Oncogene, 12, 1961–1969.
Johnson TK, Schweppe RE, Septer J and Lewis RE . (1999). J. Biol. Chem., 274, 36741–36749.
Johnson LR, Johnson TK, Desler M, Luster TA, Nowling T, Lewis RE and Rizzino A . (2002). J. Biol. Chem., 277, 4088–4097.
Kamano H, Burk B, Noben-Trauth K and Klempnauer K-H . (1995). Oncogene, 11, 2575–2582.
Kamano H and Klempnauer K-H . (1997). Oncogene, 14, 1223–1229.
Lam EW, Robinson C and Watson RJ . (1992). Oncogene, 7, 1885–1890.
Lam EW and Watson RJ . (1993). EMBO J., 12, 2705–2713.
Lane S, Farlie P and Watson R . (1997). Oncogene, 14, 2445–2453.
Li X and McDonnell DP . (2002). Mol. Cell. Biol., 11, 3663–3673.
Lin D, Fiscella M, O’Connor PM, Jackman J, Chen M, Luo LL, Sala A, Travali S, Appella E and Mercer WE . (1994). Proc. Natl. Acad. Sci. USA, 91, 10079–10083.
Lundblad JR, Kwok RP, Laurance ME, Harter ML and Goodman RH . (1995). Nature, 374, 85–88.
Martinez-Balbas MA, Bauer UM, Nielsen SJ, Brehm A and Kouzarides T . (2000). EMBO J., 19, 662–671.
Marzio G, Wagener C, Gutierrez MI, Cartwright P, Helin K and Giacca M . (2000). J. Biol. Chem., 275, 10887–10892.
Mink S, Haenig B and Klempnauer K-H . (1997). Mol. Cell. Biol., 17, 6609–6617.
Neuman E, Ladha MH, Lin N, Upton TM, Miller SJ, DiRenzo J, Pestell RG, Hinds PW, Dowdy SF, Brown M and Ewen ME . (1997). Mol. Cell. Biol., 17, 5338–5347.
Nomura N, Takahashi M, Matsui M, Ishii S, Date T, Sasamoto S and Ishizaki R . (1988). Nucleic Acids Res., 16, 11075–11089.
Oelgeschlaeger M, Janknecht R, Krieg J, Schreek S and Luscher B . (1996). EMBO J., 15, 2771–2780.
Ogryzko VV, Schiltz RL, Russanova V, Howard BH and Nakatani Y . (1996). Cell, 87, 953–959.
Ratineau C, Petry MW, Mutoh H and Leiter AB . (2002). J. Biol. Chem., 277, 8847–8853.
Robinson C, Light Y, Groves R, Mann D, Marais R and Watson R . (1996). Oncogene, 12, 1855–1864.
Sala A, Kundu M, Casella I, Engelhard A, Calabretta B, Grasso L, Paggi MG, Giordano A, Watson RJ, Khalili K and Peschle C . (1997). Proc. Natl. Acad. Sci. USA, 94, 532–536.
Sano Y and Ishii S . (2001). J. Biol. Chem., 276, 3674–3682.
Saville MK and Watson RJ . (1998). Oncogene, 17, 2679–2689.
Schwartz C, Beck K, Mink S, Schmolke M, Budde B, Wenning D and Klempnauer K-H . (2003). EMBO J., 22, 882–892.
Sherr CJ . (1995a). Trends Biochem. Sci., 20, 187–190.
Sherr CJ . (1995b). Proc. Assoc. Am. Phys., 107, 181–186.
Sitzmann J, Noben-Trauth K, Kamano H and Klempnauer K-H . (1996). Oncogene, 12, 1889–1894.
Skapek SX, Rhee J, Kim PS, Novitch BG and Lassar AB . (1996). Mol. Cell. Biol., 16, 7043–7053.
Skapek SX, Rhee J, Spicer DB and Lassar AB . (1995). Science, 267, 1022–1024.
Tomita A, Towatari M, Tsuzuki S, Hayakawa F, Kosugi H, Tamai K, Miyazaki T, Kinoshita T and Saito H . (2000). Oncogene, 19, 444–451.
Tsukiyama T and Wu C . (1997). Curr. Opin. Genet. Dev., 7, 182–191.
Weinberg RA . (1995). Cell, 81, 323–330.
Ziebold U, Bartsch O, Marais R, Ferrari S and Klempnauer K-H . (1997). Curr. Biol., 7, 253–260.
Ziebold U and Klempnauer K-H . (1997). Oncogene, 15, 1011–1019.
Zwicker J, Liu N, Engeland K, Lucibello FC and Muller R . (1996). Science, 271, 1595–1597.
Zwijsen RM, Wientjens E, Klompmaker R, van der Sman J, Bernards R and Michalides RJ . (1997). Cell, 88, 405–415.
Acknowledgements
We thank S Ferrari and C Schwartz for valuable discussions, A Brehmer-Fastnacht and D Wenning for excellent technical assistance, A Hecht for providing the HAT-deficient p300 mutant and RE Lewis for providing B-Myb mutants. This study was supported by a grant from the DFG (KL 461/9-2) and by the Fonds der chemischen Industrie.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schubert, S., Horstmann, S., Bartusel, T. et al. The cooperation of B-Myb with the coactivator p300 is orchestrated by cyclins A and D1. Oncogene 23, 1392–1404 (2004). https://doi.org/10.1038/sj.onc.1207255
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207255
Keywords
This article is cited by
-
The role of MYB proto-oncogene like 2 in tamoxifen resistance in breast cancer
Journal of Molecular Histology (2021)
-
Characterization of the zinc finger proteins ZMYM2 and ZMYM4 as novel B-MYB binding proteins
Scientific Reports (2020)
-
Cathepsin L induced PC-12 cell apoptosis via activation of B-Myb and regulation of cell cycle proteins
Acta Pharmacologica Sinica (2019)
-
Interplay with the Mre11-Rad50-Nbs1 complex and phosphorylation by GSK3β implicate human B-Myb in DNA-damage signaling
Scientific Reports (2017)
-
MYBL2 (B-Myb): a central regulator of cell proliferation, cell survival and differentiation involved in tumorigenesis
Cell Death & Disease (2017)